Study guide
Ex Rx for Pulmonary Disease (COPD, asthma; breathing techniques, supplemental O2)
ACSM Certified Clinical Exercise Physiologist ACSM-CEP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 The ACSM-CEP Role, Job Definition & Scope of Practice 1.2 Exam Format, Domain Weights & Scoring 1.3 Eligibility, Study Planning & Test-Day Strategy
2 Applied Exercise Physiology & Metabolic Calculations
Bioenergetics & Energy Systems (ATP-PC, glycolytic, oxidative) Acute Cardiorespiratory & Metabolic Responses to Aerobic Exercise Responses to Resistance Exercise & Chronic Training Adaptations ACSM Metabolic Equations, METs & Interpreting VO₂ / RER / Ventilatory Threshold
3 Pathophysiology of Clinical Populations
3.1 Coronary Artery Disease, Myocardial Infarction & Revascularization (PCI/CABG) 3.2 Heart Failure, Valvular Disease & Cardiac Rhythm Disorders 3.3 Hypertension, Dyslipidemia & Peripheral Artery Disease 3.4 Pulmonary Disease: COPD, Asthma & Restrictive/Interstitial Disorders 3.5 Diabetes, Metabolic Syndrome & Obesity 3.6 Renal Disease & Musculoskeletal/Orthopedic Conditions 3.7 Neuromuscular, Neurological & Cognitive Conditions (stroke, MS, Parkinson's, SCI) 3.8 Neoplastic, Immunologic & Hematologic Disorders (cancer, HIV/AIDS, anemia)
4 Clinical ECG Interpretation
4.1 ECG Leads, Waveforms, Rate & Rhythm Determination 4.2 Arrhythmias & Conduction Blocks 4.3 Ischemia, Injury & Infarction (ST changes, exercise-induced) 4.4 Drug & Electrolyte ECG Effects; Resting/Exercise Monitoring Setup & Lead Placement
5 Pharmacology for the Clinical Exercise Physiologist
5.1 Beta-Blockers, Calcium-Channel Blockers & Nitrates 5.2 RAAS Agents, Diuretics, Antiarrhythmics, Lipid-Lowering & Antithrombotic Drugs 5.3 Bronchodilators, Corticosteroids, Insulin & Oral Antidiabetic Agents 5.4 Medication Effects on HR/BP & Exercise Response; Dose/Meal/Dialysis Timing
6 Patient Assessment (Domain I, 18%)
6.1 Medical Records, HIPAA/HITRUST, Charting & Physician Referral 6.2 Patient Interview, Medical History & Medication Reconciliation 6.3 Resting Vital Signs, Body Composition & Resting ECG 6.4 Preparticipation Health Screening & Level of Monitoring (PAR-Q+, ACSM algorithm, ACC/AHA · GOLD · ADA · AACVPR) 6.5 Assessing Patient Goals, Readiness & Psychosocial Status
7 Clinical Exercise Testing (Domain II, 18%)
Submaximal Aerobic Tests (treadmill, cycle, step, 6-minute walk) Musculoskeletal Fitness, Mobility & Balance Testing Maximal Symptom-Limited GXT: Protocols, Contraindications & ECG Prep Test Termination: Relative & Absolute Indications Interpreting & Reporting Results (ECG response, RPP, claudication, Duke Treadmill Score, VO₂/RER/AT)
8 Exercise Prescription for Clinical Populations (Domain III, 22%)
FITT-VP Principles, Progression & Prescription Foundations Ex Rx for Cardiovascular Disease (CAD, HF, HTN, PAD, post-revascularization) Ex Rx for Pulmonary Disease (COPD, asthma; breathing techniques, supplemental O2) Ex Rx for Diabetes, Metabolic Syndrome & Obesity Ex Rx for Musculoskeletal, Neuromuscular, Neoplastic & Other Conditions Communicating Intensity (THR, RPE, talk test), Monitoring & Modifying the Prescription
9 Exercise Training & Leadership (Domain IV, 24%)
9.1 Discussing the Training Plan, Clinician & Patient Expectations/Goals 9.2 Instructing & Modifying Exercise Modes (cardiorespiratory, strength/endurance, flexibility, coordination, agility) 9.3 Patient Monitoring & Supervision During Exercise (telemetry, oximetry, glucometry, ECG) 9.4 Contraindications to Training & Modifying Recommendations 9.5 Documenting Clinical Status, Reporting Adverse Events & Interdisciplinary Coordination
10 Education & Behavior Change (Domain V, 13%)
10.1 Behavioral-Health Screening & Recognizing Distress (PHQ-9, Beck, SF-36; referral) 10.2 Patient Education, Health Literacy & Disease Self-Management 10.3 Motivational Interviewing & Behavior-Change Theories (Transtheoretical, HBM, Social Cognitive, Five-A's) 10.4 Promoting Adherence, Self-Efficacy, Relapse Prevention & Social Support
11 Legal, Professional & Emergency Management (Domain VI, 5%)
11.1 Emergency Equipment, Crash Cart Inspection & Emergency Procedures 11.2 CPR/AED/BLS/ACLS, Universal Precautions & EMS Activation 11.3 Scope of Practice, Legal/Ethical Standards, Liability/Negligence, Informed Consent & Professional Organizations (ACSM/AACVPR/AHA)
Ex Rx for Pulmonary Disease (COPD, asthma; breathing techniques, supplemental O2)
Key Takeaways Explain This Topic AI
COPD prescription is dyspnea-driven: 60-80% peak work rate or modified Borg dyspnea 4-6/10, often using interval bouts because ventilatory limitation, not cardiac limitation, ends the exercise bout.
Pursed-lip breathing prolongs expiration and reduces dynamic hyperinflation; diaphragmatic breathing reduces accessory-muscle work of breathing.
Exercising SpO2 must stay above 88%; if it falls to 88% or below on room air, supplemental oxygen is added or increased under physician order, sometimes at a higher flow rate than the resting prescription.
Upper-body resistance/endurance training is emphasized in COPD because it directly reduces the dyspnea cost of overhead and reaching activities of daily living.
Asthma patients with exercise-induced bronchospasm history should pretreat with a rescue inhaler about 15 minutes before exercise and keep it accessible during the session.
Last updated: July 2026
COPD: FITT and Interval Training
Patients with chronic obstructive pulmonary disease (COPD) are frequently ventilatory-limited rather than cardiac-limited, so their exercise prescription centers on dyspnea tolerance as much as heart rate. Typical FITT parameters are frequency 3–5 days/week (up to daily, using short bouts, for the most deconditioned patients), intensity 60–80% of peak work rate or a dyspnea-based target using the modified 0–10 Borg dyspnea scale , aiming for roughly 4–6 ("somewhat severe" to "severe"). Many COPD patients cannot sustain continuous exercise at a useful training intensity, so interval training — short work bouts (30 seconds to a few minutes) alternated with rest or low-intensity recovery — is used to accumulate a meaningful training dose while keeping ventilatory demand manageable. Session time progresses gradually toward 20–30 continuous minutes as tolerance improves. Beyond walking or cycling, upper-body resistance and endurance training is a key mode for COPD because it reduces the accessory-muscle (and therefore dyspnea) cost of overhead and reaching activities of daily living.
Breathing Techniques
Two techniques are taught directly to COPD patients as part of the prescription:
Pursed-lip breathing — exhaling slowly through pursed lips prolongs expiration, creates back-pressure that splints the airways open, and reduces dynamic hyperinflation (air trapping), which is often the direct cause of exertional dyspnea in COPD.
Diaphragmatic (abdominal) breathing — emphasizes diaphragmatic descent over accessory-muscle use, reducing the work of breathing at rest and during low-level activity.
Inspiratory muscle training is a useful adjunct for patients with measurable respiratory muscle weakness, using a resistive or threshold-loading device to strengthen the diaphragm and accessory inspiratory muscles.
Supplemental Oxygen
ACSM and GOLD guidance is consistent: exercising SpO2 should be maintained above 88% . If SpO2 falls to 88% or below on room air during activity, supplemental oxygen should be added or increased to keep saturation above that threshold; use of supplemental oxygen requires a physician's order, and patients already on long-term oxygen therapy may need a higher flow rate during exercise than they use at rest. Continuous pulse-oximetry monitoring is standard during initial sessions, especially for patients with a history of exercise-induced desaturation (commonly defined as a drop of more than 4 percentage points from resting SpO2, or a fall below 88%). If SpO2 cannot be kept above the prescribed threshold, or the patient's dyspnea rating exceeds the prescribed ceiling, the session is modified (lower workload, longer rest intervals) or stopped.
Restrictive and Interstitial Lung Disease
Patients with restrictive lung disease (interstitial pulmonary fibrosis, thoracic wall or neuromuscular restriction) share the ventilatory-limitation pattern seen in COPD but often desaturate more abruptly and at lower workloads, so pulse oximetry monitoring is applied even more conservatively — checking every 1–2 minutes during the first several sessions rather than only at stage changes. Interval training and dyspnea-based (rather than HR-based) intensity apply here as well, and many of these patients are already on supplemental oxygen at rest, so the exercise prescription should confirm the correct exertional flow rate with the prescribing pulmonologist rather than assuming the resting rate is sufficient during activity.
Asthma and Exercise-Induced Bronchospasm
For patients with a history of exercise-induced bronchospasm, a short-acting beta-agonist (rescue inhaler) is typically used about 15 minutes before exercise , along with a gradual, extended warm-up. Cold, dry air is a common trigger, so indoor or warm/humid environments are preferred when available, and a rescue inhaler should always be accessible during the session in case symptoms emerge despite pretreatment.
Monitoring and Modification Summary
- Signal Action threshold Response
- SpO2 on room air ≤88% during exercise Add/increase supplemental O2 to keep SpO2 >88%
- Dyspnea (modified Borg 0–10) Above prescribed ceiling (often >6–7) Reduce workload or extend rest interval
History of exercise-induced bronchospasm — Pretreat with rescue inhaler ~15 min pre-exercise; keep inhaler accessible
Respiratory distress signs Any onset Stop session; reassess before resuming
Across pulmonary populations, the exercise physiologist prescribes to the patient's tolerable dyspnea , not solely to a heart-rate zone — HR is frequently a poor guide in advanced lung disease because ventilatory limitation, not cardiac limitation, is what ends the exercise bout.
Oxygen Titration and Session Setup
Before the first exercise session, an oxygen titration trial — typically performed under the pulmonologist's or exercise physiologist's supervision during a submaximal walk test — establishes the exertional flow rate needed to keep SpO2 above 88% at the prescribed workload. That titrated rate, not the resting prescription, is what is used during training sessions, and it may need to be re-titrated if the prescribed exercise intensity is later progressed. Portable oxygen equipment should be checked for adequate supply before every session, and the CEP confirms the patient can operate their own delivery device (nasal cannula flow adjustment, portable concentrator settings) for use in home and community settings outside of supervised sessions.